APA

Dey K. K., Bharti R., Dey G., Pal I., Rajesh Y., Chavan S., Das S., Das C. K., Jena B. C., Halder P., Ray J. G., Kulavi I. & Mandal M. (20180108). S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway. : Cancer gene therapy.

Chicago

Dey K K, Bharti R, Dey G, Pal I, Rajesh Y, Chavan S, Das S, Das C K, Jena B C, Halder P, Ray J G, Kulavi I and Mandal M. 20180108. S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway. : Cancer gene therapy.

Harvard

Dey K. K., Bharti R., Dey G., Pal I., Rajesh Y., Chavan S., Das S., Das C. K., Jena B. C., Halder P., Ray J. G., Kulavi I. and Mandal M. (20180108). S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway. : Cancer gene therapy.

MLA

Dey K K, Bharti R, Dey G, Pal I, Rajesh Y, Chavan S, Das S, Das C K, Jena B C, Halder P, Ray J G, Kulavi I and Mandal M. S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway. : Cancer gene therapy. 20180108.